Trials / Withdrawn
WithdrawnNCT02444286
The RESHAPE-HF1-FU Study
Observational Study of Heart Failure Patients With Clinically Significant Functional Mitral Regurgitation - Follow Up of the Former Participants in the RESHAPE-HF Trial (Abbott Vascular).
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety and efficiency of the MitraClip system in the treatment of patients with clinically significant mitral regurgitation with New York Heart Association (NYHA) Functional Class II to IV chronic heart failure.
Detailed description
The purpose of the RESHAPE-HF1-FU Study is to follow up the safety and effectiveness of the MitraClip System in the treatment of clinically significant Functional Mitral Regurgitation (FMR) in patients with New York Heart Association (NYHA) Functional Class III or IV chronic heart failure, former participants in the RESHAPE-HF Trial (Abbott Vascular).
Conditions
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2018-01-01
- Completion
- 2018-01-01
- First posted
- 2015-05-14
- Last updated
- 2024-01-05
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT02444286. Inclusion in this directory is not an endorsement.